Kiniksa Pharmaceuticals · 1 day ago
Director, Institutional Marketing
Kiniksa Pharmaceuticals is seeking a Director of Institutional Marketing to oversee marketing activities for ARCALYST® aimed at Healthcare Professionals. The role involves developing strategies, managing resources, and collaborating with various teams to drive marketing initiatives focused on Recurrent Pericarditis Centers.
BiopharmaBiotechnologyMedical
Responsibilities
Collaborate with key stakeholders to develop and refine the marketing strategy and tactical plan focused on Recurrent Pericarditis Centers
Lead the development and creation of all resources, tools, and materials for the TLL team
Where appropriate, coordinate compliant cross-functional initiatives with Recurrent Pericarditis Centers
Drive development of HCP facing tactics, including brand messaging, digital initiatives, congress management, promotional materials, and educational activities
Manage agency partners and vendors on creation of marketing materials, materials reviews and budget adherence
Drive development and approval of materials through the Medical Review Committee (MRC) and/or Promotional Review Committee (PRC) and integrate feedback accordingly to ensure compliant execution
In partnership with the TLL team, engage with HCPs and the KOL community to understand needs and solicit insights that can be translated into strategically aligned initiatives and/or resources
Manage timelines, budgets, and resources to commercial and corporate objectives
Qualification
Required
Requires a bachelor's degree (MBA or advanced degree preferred) with 7+ years of experience in a brand marketing role within the biopharmaceutical industry
Candidate should have field experience (TLL, sales role or similar)
Candidate should have strong digital marketing experience
Strong organizational and project management skills
Team player that can also independently drive projects to completion
Solution-oriented, strong analytical and presentation skills
Ability to drive innovative thinking
Ability to multi-task in an extremely fast-paced environment with changing priorities
Strong commitment to compliance and ethical standards
Strong communicator across all levels of the organization
Ability to travel up to 30%
Preferred
Rare disease / specialty pharma experience is an asset, but not required
Benefits
Bonus
Company
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Funding
Current Stage
Public CompanyTotal Funding
$400MKey Investors
Baker Brothers Advisors LLC
2020-05-13Post Ipo Equity· $80M
2018-05-23IPO
2018-02-01Series C· $200M
Leadership Team
Recent News
GlobeNewswire
2026-01-13
2025-12-09
2025-10-29
Company data provided by crunchbase